Gene Expression Regulation and Epigenetics in Disease

Gene expression regulation determines when and how strongly genes are transcribed and translated, and epigenetic mechanisms are the heritable, sequence-independent changes — DNA methylation, histone modification, and chromatin remodelling — that help control it. Disease can arise not only from mutations in DNA but from disordered regulation that silences protective genes or activates harmful ones without changing the underlying sequence.

Definition

Gene expression regulation is the set of processes controlling the production of gene products; epigenetics is the study of heritable changes in gene activity that occur without alteration of the DNA sequence, such as DNA methylation and histone modification.

Scope

This topic covers the principal layers of gene expression control, the core epigenetic mechanisms and their role in development and disease, and how aberrant DNA methylation and chromatin changes contribute to cancer and other conditions. It is a molecular pathology reference and does not constitute clinical or therapeutic guidance.

Core questions

• What are the main levels at which gene expression is regulated?
• How do epigenetic marks such as DNA methylation and histone modifications influence transcription?
• How does epigenetic dysregulation contribute to cancer and other disease?
• How are epigenetic changes distinguished from genetic mutations in pathogenesis?

Key concepts

• Transcriptional and post-transcriptional regulation
• DNA methylation (CpG islands)
• Histone modification and chromatin remodelling
• Promoter hypermethylation and gene silencing
• Global hypomethylation
• Non-coding RNA regulation

Key theories

Epigenetic dysregulation in cancer

Cancer cells show a characteristic pattern of epigenetic alteration — global hypomethylation alongside promoter hypermethylation that silences tumour suppressor genes, together with disrupted histone modification — establishing epigenetic change as a route to malignancy that complements genetic mutation.

Mechanisms

Gene expression is controlled at several levels, including chromatin accessibility, transcription-factor binding, transcription, RNA processing and stability, and translation. Epigenetic mechanisms set much of this context: DNA methylation at CpG-rich promoters typically represses transcription, histone modifications mark chromatin as active or silent, and chromatin-remodelling complexes reposition nucleosomes to expose or hide regulatory regions; non-coding RNAs add a further regulatory layer. In disease, this control can break down — for example, hypermethylation can silence a tumour suppressor while genome-wide hypomethylation and altered histone marks destabilise normal expression programmes — so that a cell acquires disease-driving behaviour without any change in DNA sequence.

Clinical relevance

Epigenetic and expression patterns inform molecular subtyping of tumours and the interpretation of methylation and expression assays in pathology and laboratory medicine. This entry explains the mechanisms for educational reference and does not direct testing or treatment for any individual.

History

The recognition that DNA methylation and chromatin structure regulate gene activity matured through the late twentieth century, and the demonstration that promoter hypermethylation silences tumour suppressor genes brought epigenetics squarely into cancer pathogenesis. Syntheses of the molecular hallmarks of epigenetic control and reviews of epigenetics in cancer consolidated the field within molecular pathology.

Key figures

• Manel Esteller
• C. David Allis
• Thomas Jenuwein
• Adrian Bird

Seminal works

• esteller-2008
• hanahan-weinberg-2011

Frequently asked questions

How is epigenetics different from genetics?

Genetics concerns the DNA sequence itself, whereas epigenetics concerns heritable changes in gene activity — such as DNA methylation or histone modification — that switch genes on or off without altering the sequence.

Can epigenetic changes cause cancer?

Epigenetic dysregulation, such as methylation that silences a tumour suppressor gene, can contribute to cancer alongside genetic mutations by changing which genes are active.